Mohammad A speculated that ATM deficiency might increase the sensitivity of leukemic blasts to the chemotherapy used during induction and after disease remission in patients with adult ALL (Acute Lymphoblastic Leukemia) [25]. This evidence concerns the gene ATM and acute lymphoblastic leukemia.